Antioxidant activity of amiodarone on human lipoprotein oxidation

British Journal of Pharmacology

Volumn 133, Issue 5, 2001, Pages 739-745

  Lapenna, D ^a   Ciofani, G ^a   Bruno, C ^a   Pierdomenico, S D ^a   Cuccurullo, F ^a  

^a Patologia Medica   (Italy)

Author keywords

Amiodarone; Antioxidants; Atherosclerosis; Lipoprotein oxidation

Indexed keywords

AMIODARONE; ANTIOXIDANT;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHEMICAL MODIFICATION; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HUMAN; HYDROPHOBICITY; LIPID OXIDATION; LIPID PEROXIDATION; LIPOPHILICITY; LIPOPROTEIN METABOLISM; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RECEPTOR BINDING;

ADULT; AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ANTIOXIDANTS; COPPER; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; LIPID PEROXIDATION; LIPID PEROXIDES; LIPOPROTEINS; MIDDLE AGED; OXIDATION-REDUCTION; SPECTROMETRY, FLUORESCENCE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS;

EID: 0034938619     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704126     Document Type: Article

References (51)

1. Simulation of lipid peroxidation in low density lipoprotein by a basic skeleton of reactions
2. Amiodarone and its desethyl metabolite: Tissue distribution and morphologic changes during long-term therapy
3. Oxidisability of low density lipoprotein in patients with carotid or femoral artery atherosclerosis
4. The role of oxidized lipoprotein in atherogenesis
5. Antioxidant determination by the use of a stable free radical
6. Calcium antagonists prevent monocyte and endothelial cell-mediated modification of low density lipoproteins
7. Phenothiazines inhibit copper- and endothelial cell-induced peroxidation of low density lipoprotein
8. Amiodarone induced modifications of the phospholipid physical state. A fluorescence polarization study
9. Phytic acid as a food antioxidant
10. The role of lipid peroxidation and antioxidants in oxidative modification of LDL
11. Metal ion release from mechanically-disrupted human arterial wall. Implication for the development of atherosclerosis
12. A fluorometric micromethod for serum vitamin A and E
13. Plasma and red blood cell concentrations of amiodarone during chronic therapy
14. Oxidation of low density lipoprotein by thiols: Superoxide-dependent and -independent mechanisms
15. Quantitation of lipid peroxidation in tissue extracts based on Fe (III) xylenol orange complex formation
16. Amiodarone pharmacokinetics
17. Amiodarone protects cardiac myocytes against oxidative injury by its free radical scavenging action
18. Clinical measurement of serum amiodarone and desethylamiodarone by using solid-phase extraction followed by HPLC with a high-carbon reversed-phase column
19. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein
20. Site-specific trapping of reactive species in low-density lipoprotein oxidation: Biological implications
21. Role of lipoprotein-copper complex in copper catalized-peroxidation of low-density lipoprotein
22. Binding of amiodarone by serum proteins and the effects of drugs, hormones and other ligands
23. Antioxidant properties of ticlopidine on human low density lipoprotein oxidation
24. Antioxidant activity of allopurinol on copper-catalysed human lipoprotein oxidation
25. The oxidative modification of low-density lipoproteins by macrophages
26. Protein measurement with Folin phenol reagent
27. Mechanisms of copper- and iron-dependent oxidative modification of human low density lipoprotein
28. Potent inhibitory activities of hydrophobic aci-reductones (2-hydroxytetronic acid analogs) against membrane and human low-density lipoprotein oxidation
29. Antioxidant properties of calcium antagonists related to membrane biophysical interactions
30. Lipophilic β-blockers inhibit monocyte and endothelial cell-mediated modification of low density lipoprotein
31. Antioxidant activity of probucol and its effects on phase transitions in phosphatidylcholine liposomes
32. Effects of membrane-stabilizing agents, cholesterol and cepharantin, on radiation-induced lipid peroxidation and permeability in liposomes
33. Characterization of liposomes
34. Dynamics of the oxidation of low density lipoprotein induced by free radicals
35. Assay for lipid peroxidation in animal tissue by thiobarbituric acid reaction
36. The resistance of low density lipoprotein to oxidation promoted by copper and its use as an index of antioxidant therapy
37. Garlic supplementation and lipoprotein oxidation susceptibility
38. A rapid screening test to determine the antioxidant potencies of natural and synthetic antioxidants
39. Molecular pharmacological aspect of antiarrhythmic activity. Class I and class III compounds and lipid peroxidation
40. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man
41. Evaluation of amiodarone free radical toxicity in rat hepatocytes
42. Lipoprotein oxidation and progression of carotid atherosclerosis
43. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions
44. Role of superoxide in endothelial cell modification of low-density lipoprotein
45. Protective actions of tamoxifen and 4-hydroxytamoxifen against oxidative damage to human low-density lipoproteins: A mechanism accounting for cardioprotective action of tamoxifen?
46. Role of oxidized low density lipoprotein in atherogenesis
47. Effect of selected antiarrhythmic drugs on the superoxide anion production by polymorphonuclear neutrophils in vitro
48. A rapid and simple method for measuring the susceptibility of low-density-lipoporotein and very-low-density-lipoprotein to copper-catalized oxidation
49. Management of cardiac arrhythmias: Pharmacological, electrical, and surgical techniques